REPRIEVE (A5332) is a large double-blind, randomized, placebo-controlled study of pitavastatin or placebo for about 72 months....
IMPAACT 2010 is a Phase III, three-arm, randomized, open-label study of HIV-1-infected pregnant women initiating either a...
Study of MDR TB Cases and Their Household Contacts: Operational Feasibility to Inform PHOENIx Trial Design
The investigators are looking for a better way to prevent cervical cancer. This study is comparing two different methods to...
We will address our hypothesis using a case-control study design. We plan to leverage the existing biorepository of...
